JP4472870B2 - 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用 - Google Patents

分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用 Download PDF

Info

Publication number
JP4472870B2
JP4472870B2 JP2000541204A JP2000541204A JP4472870B2 JP 4472870 B2 JP4472870 B2 JP 4472870B2 JP 2000541204 A JP2000541204 A JP 2000541204A JP 2000541204 A JP2000541204 A JP 2000541204A JP 4472870 B2 JP4472870 B2 JP 4472870B2
Authority
JP
Japan
Prior art keywords
chimeric protein
amino acid
acid sequence
insulin
peptidyl fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000541204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505601A5 (enExample
JP2004505601A (ja
Inventor
ガン，ツォンル
Original Assignee
トンファ ガンテク バイオテクノロジー リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4575041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4472870(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by トンファ ガンテク バイオテクノロジー リミティド filed Critical トンファ ガンテク バイオテクノロジー リミティド
Publication of JP2004505601A publication Critical patent/JP2004505601A/ja
Publication of JP2004505601A5 publication Critical patent/JP2004505601A5/ja
Application granted granted Critical
Publication of JP4472870B2 publication Critical patent/JP4472870B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2000541204A 1998-03-31 1998-03-31 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用 Expired - Fee Related JP4472870B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN1998/000052 WO1999050302A1 (en) 1998-03-31 1998-03-31 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production

Publications (3)

Publication Number Publication Date
JP2004505601A JP2004505601A (ja) 2004-02-26
JP2004505601A5 JP2004505601A5 (enExample) 2005-12-22
JP4472870B2 true JP4472870B2 (ja) 2010-06-02

Family

ID=4575041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000541204A Expired - Fee Related JP4472870B2 (ja) 1998-03-31 1998-03-31 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用

Country Status (15)

Country Link
US (1) US6924120B1 (enExample)
EP (1) EP1066328B1 (enExample)
JP (1) JP4472870B2 (enExample)
KR (1) KR100554490B1 (enExample)
CN (1) CN1197876C (enExample)
AT (1) ATE408631T1 (enExample)
AU (1) AU765574B2 (enExample)
BR (1) BR9815788B1 (enExample)
CA (1) CA2324513C (enExample)
DE (1) DE69840035D1 (enExample)
DK (1) DK1066328T3 (enExample)
ES (1) ES2317665T3 (enExample)
IL (1) IL138658A0 (enExample)
MX (1) MXPA00009564A (enExample)
WO (1) WO1999050302A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372199A1 (en) * 1999-05-14 2000-11-23 Medical Research Council Oligomeric chaperone proteins
JP2003502024A (ja) * 1999-05-14 2003-01-21 メディカル リサーチ カウンシル タンパク質骨格および単量体ポリペプチドを多量体化するためのその使用
GB9913437D0 (en) * 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
EP2336164A1 (en) 2005-12-22 2011-06-22 Genentech, Inc. Recombinant production of heparin binding proteins
WO2008008975A2 (en) 2006-07-14 2008-01-17 Genentech, Inc. Refolding of recombinant proteins
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
RU2447149C1 (ru) * 2011-03-24 2012-04-10 Винсорт Менеджемент Инк РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pMSIN4, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД - ПРЕДШЕСТВЕННИК ИНСУЛИНА ЧЕЛОВЕКА, ШТАММ BL21(DE3)/pMSIN4-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА
CN102628072B (zh) * 2012-03-20 2013-12-04 甘李药业股份有限公司 一种胰岛素的制备方法
CN103439512B (zh) * 2013-07-30 2014-05-07 通化东宝药业股份有限公司 一种检测特异性重组人胰岛素大肠杆菌残留宿主蛋白的方法
CN112142848A (zh) * 2019-06-26 2020-12-29 中国科学院大连化学物理研究所 一种重组人胰岛素及其纯化制备方法
CN114805610B (zh) * 2022-06-23 2022-10-04 北京惠之衡生物科技有限公司 一种高表达甘精胰岛素前体的重组基因工程菌及其构建方法
CN114805544B (zh) * 2022-06-23 2022-09-09 北京惠之衡生物科技有限公司 一种赖脯胰岛素前体、其重组基因工程菌及其构建方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US5254463A (en) 1981-09-18 1993-10-19 Genentech, Inc. Method for expression of bovine growth hormone
US4665160A (en) * 1982-03-22 1987-05-12 Genentech, Inc. Novel human growth hormone like protein HGH-V encoded in the human genome
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US5191063A (en) 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
US5358857A (en) 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
US5422110A (en) 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
SG46612A1 (en) 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
US6001604A (en) 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DK0871474T4 (da) * 1994-12-29 2012-01-09 Ferring Int Ct Sa Fremstilling af human insulin
CA2212006A1 (en) * 1995-02-03 1996-08-08 G.D. Searle & Co. Novel c-mpl ligands
US5559128A (en) 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
AUPO394896A0 (en) 1996-11-29 1997-01-02 May, Peter Andrew John Hose mounting bracket
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors

Also Published As

Publication number Publication date
BR9815788B1 (pt) 2013-06-04
ATE408631T1 (de) 2008-10-15
AU6716498A (en) 1999-10-18
EP1066328B1 (en) 2008-09-17
CA2324513C (en) 2013-05-28
CA2324513A1 (en) 1999-10-07
WO1999050302A1 (en) 1999-10-07
IL138658A0 (en) 2001-10-31
EP1066328A4 (en) 2002-06-05
EP1066328A1 (en) 2001-01-10
US6924120B1 (en) 2005-08-02
DK1066328T3 (da) 2009-02-09
JP2004505601A (ja) 2004-02-26
KR20010042383A (ko) 2001-05-25
AU765574B2 (en) 2003-09-25
DE69840035D1 (de) 2008-10-30
MXPA00009564A (es) 2004-03-10
KR100554490B1 (ko) 2006-03-03
ES2317665T3 (es) 2009-04-16
CN1197876C (zh) 2005-04-20
BR9815788A (pt) 2000-11-28
CN1291199A (zh) 2001-04-11

Similar Documents

Publication Publication Date Title
AU648670B2 (en) A-C-B Proinsulin, method of manufacturing and using same, and intermediates in insulin production
AU605291B2 (en) Process for the purification of recombinant polypeptides
JP4472870B2 (ja) 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用
JPH11130798A (ja) 正しく結合したシスチン橋を有するインスリン前駆体を取得するための改良された方法
JP2006223316A (ja) 組換えフィブリン鎖、フィブリンおよびフィブリン−ホモログ
CA2257122C (en) Method of activating denatured protein
Kadonookuda et al. Baculovirus-mediated production of the human growth hormone in larvae of the silkworm, Bombyx mori
JP2001008697A (ja) Ｅ．コリでの非融合タンパク質の調製方法
US5310882A (en) Somatotropins with alterations in the α-helix 3 region
JP2005523001A (ja) 二量体増殖因子を調製するための材料と方法
US20020164712A1 (en) Chimeric protein containing an intramolecular chaperone-like sequence
US5548068A (en) Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
WO2006018428A2 (en) Hemopexin fusion proteins
RU2238951C2 (ru) Химерный белок, обеспечивающий образование биоактивной конформации, способ получения белка с инсулиновой активностью, способ идентификации пептидильного фрагмента
US20080064630A1 (en) Osteogenic Growth Peptide Fusion Proteins
JPS62501071A (ja) 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
NZ260176A (en) Method for site directed mutagenesis on recombinantly derived polypeptide or protein and its application on somatotropin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050315

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081104

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091019

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20091112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100202

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100304

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140312

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees